A study on the performance and cost-effectiveness of robots in replacing manual nucleic acid collection method: Experience from the COVID-19 pandemic.

Journal: PloS one
Published Date: Nov 3, 2022

Abstract

BACKGROUND: The COVID-19 pandemic has led nucleic acid collection and detection became a measure to ensure normal life in China. Considering the huge detection demand, it has emerged that robots replace manual sample collection. However, the cost-effectiveness of nucleic acid collection by robots instead of humans remain unknown.

Authors

  • Zhuoyuan Chi
    Department of Pharmacoeconomics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
  • Yusi Tu
    Department of Pharmacoeconomics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
  • Fangfang Gong
    Shenzhen Luohu Hospital Group, Shenzhen, China.
  • Wenxi Tang
    Department of Pharmacoeconomics, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Keywords

External Resources

Popular Topics
Recent Journals